Erin Bell

Erin Bell currently serves as a Life Sciences Associate at Charles River Associates, where involvement in over 25 project teams has facilitated collaboration with leading global pharmaceutical companies on integrated strategies and research materials. This role emphasizes the analysis of scientific information, clinical study results, and competitive landscapes, thereby enhancing strategic decision-making for top-tier clients. Previously, Erin held positions as a Life Sciences Analyst at Savano Capital Partners, specializing in venture capital, and worked as a Life Sciences Intern at Charles River Associates, contributing to litigation support for intellectual property and commercial disputes. Erin holds a degree from Georgetown University McDonough School of Business, earned between 2016 and 2020.